Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > The Path

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jan 30, 2024 11:38am

76 Views

Post# 35852701

RE:RE: The Path

"Gilles, in a sense, already appears at the top of the mountain with Ronnie Miller

That's exactly what we criticize here again and again. Gilles and Ronnie with full pockets greet us from the mountain - and we stand in the valley with tears in our eyes."

You are the one with tears because you have ZERO confidence in yourself to project what the new company could be worth as we await key details, events, and details. The team of Gilles and Ronnie know more details than anyone and Gilles wants CZO's pipeline on NASDAQ. The merger fully finances CZO's near-tem revenue generating opportunities. Gilles and Ronnie have the support of Bloom Burton, Natex, Dr. Kolb, Dr. Li, and Dr. Hoare, and Dr. Tardif. The Canadian government has provided increased funding over time after its due diligence. You do not have the ability to do proper due diligence, in my opinion. You've shown no interest in posting about CZO's pipeline. You have created fantasies with revenue tripling due to PGX with no PGX plant as you have CZO paying dividends and doing share buybacks. You are not inside the deal like Gilles. A fully financed event path is before this company and that will tell the story.

The path,
the daisy chain of events that will define this merger...

AEZS's diagnostic test clinical trial results for children
Launch of powder formulations of CZO's two active ingredients(beta glucan, avenanthramide)
CZO's main client returns
AEZS's diagnostic continuing roll-out for adults
FDA approval for the test for children
Licensing deal for the diagnostic test for North America
Commissioning of 5X PGX scale-up
Commissioning of 10X scale-up to decision point for mass industrialization of PGX
PGX licensing deal
Immune booster plant
Phase I avenanthramide clinical trial results
Wound healing results
Wound healing partnership
Fibrosis clinical trial 'go'/'no go' decision and regulatory filing
Phase IIa avenanthramide clinical trial results
Avenanthramide pill partnership
AIM Biologicals 'go'/'no go' clinical trial decision

Image result for daisy chain fireworks